CCL2 and breast neoplasm: In functional studies, CCL2 antibody neutralization in 4T1 or MDA-MB-231 breast tumor xenografts inhibited tumor growth and metastasis, while decreasing the levels of macrophages in the primary tumors, indicating that CCL2 promotes progression of TNBC [21-23] through macrophage dependent mechanisms.